← Leaderboards
Julia Y Ljubimova
Cedars-Sinai Medical Center
$11,374,096
Attributed
$13,384,471
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2006–20$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$13,384,471 · 6
By mechanism
R01$10,674,374 · 5
U01$2,710,097 · 1
Top collaborators
- Manuel L Penichet7 shared
- Hui Ding1 shared
- Eggehard Holler1 shared
Most similar at Cedars-Sinai Medical Center
Same institution · by research overlap
- Moshe Arditi$23,213,171
- Tripathi Byasmuni Rajavashisth$1,678,638
- Prediman Krishan Shah$8,075,140
- Ekaterina Koltsova$9,780,046
- Behrooz G Sharifi$2,800,611
Others in their field
Top investigators on “Cancer Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$366,127,178
- Norman Wolmark · Nsabp Foundation, Inc.$292,963,206
- Gregory H Reaman · National Childhood Cancer Foundation$271,061,526
- Peter C Adamson · National Childhood Cancer Foundation$269,808,480
- Charles A Coltman · Southwest Oncology Group$178,303,465
- Sudhir Raju · Ctis, Inc.$162,436,462
Research focus
Cancer TherapyBaseCellsIn VitroTumorPharmaceutical PreparationsAcidsDrug KineticsHalf-LifeNanoconjugateMalignant NeoplasmsLeadDrug Delivery SystemsToxic EffectTumor GrowthBrainAntibodiesBrain NeoplasmsAntineoplastic AgentsNeoplastic CellAntisense OligonucleotidesBloodGliomaProteins
Grant awards (31)
Nano immunoconjugates to treat primary and metastatic HER2 positive breast cancer$637,908
R01 · FY2020 · CA · contact PI
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors$570,320
R01 · FY2020 · CA · contact PI
Nano immunoconjugates to treat primary and metastatic HER2 positive breast cancer$638,279
R01 · FY2019 · CA · contact PI
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors$541,408
R01 · FY2019 · CA · contact PI
Differential MRI imaging for brain tumor metastases diagnosis and treatment monitoring$479,493
R01 · FY2019 · CA · contact PI
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors$547,857
R01 · FY2018 · CA · contact PI
Differential MRI imaging for brain tumor metastases diagnosis and treatment monitoring$497,850
R01 · FY2018 · CA · contact PI
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors$549,102
R01 · FY2017 · CA · contact PI
Differential MRI imaging for brain tumor metastases diagnosis and treatment monitoring$511,546
R01 · FY2017 · CA · contact PI
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors$557,887
R01 · FY2016 · CA · contact PI
Differential MRI imaging for brain tumor metastases diagnosis and treatment monitoring$511,670
R01 · FY2016 · CA · contact PI
Differential MRI imaging for brain tumor metastases diagnosis and treatment monitoring$508,101
R01 · FY2015 · CA · contact PI
Novel Nanopolymers to Inhibit Angiogenesis and Increase the Anti-tumor Immunity$460,080
R01 · FY2014 · CA
Nanoconjugate based on polymalic acid for brain tumor treatment$457,921
U01 · FY2014 · CA · contact PI
Novel Nanopolymers to Inhibit Angiogenesis and Increase the Anti-tumor Immunity$148,320
R01 · FY2014 · CA
Novel Nanopolymers to Inhibit Angiogenesis and Increase the Anti-tumor Immunity$454,899
R01 · FY2013 · CA
Nanoconjugate based on polymalic acid for brain tumor treatment$452,587
U01 · FY2013 · CA · contact PI
Novel Nanopolymers to Inhibit Angiogenesis and Increase the Anti-tumor Immunity$140,921
R01 · FY2013 · CA
Novel Nanopolymers to Inhibit Angiogenesis and Increase the Anti-tumor Immunity$493,702
R01 · FY2012 · CA
Nanoconjugate based on polymalic acid for brain tumor treatment$484,749
U01 · FY2012 · CA · contact PI
Nanoconjugate based on polymalic acid for brain tumor treatment$157,231
U01 · FY2012 · CA · contact PI
Novel Nanopolymers to Inhibit Angiogenesis and Increase the Anti-tumor Immunity$503,602
R01 · FY2011 · CA
Nanoconjugate based on polymalic acid for brain tumor treatment$486,001
U01 · FY2011 · CA · contact PI
Nanoconjugate based on polymalic acid for brain tumor treatment$157,231
U01 · FY2011 · CA · contact PI
Novel Nanopolymers to Inhibit Angiogenesis and Increase the Anti-tumor Immunity$543,040
R01 · FY2010 · CA
Nanoconjugate based on polymalic acid for brain tumor treatment$514,377
U01 · FY2010 · CA · contact PI
Tumor drug delivery systems based on polymalic acid$274,041
R01 · FY2010 · CA · contact PI
Tumor drug delivery systems based on polymalic acid$274,041
R01 · FY2009 · CA · contact PI
Tumor drug delivery systems based on polymalic acid$274,041
R01 · FY2008 · CA · contact PI
Tumor drug delivery systems based on polymalic acid$274,041
R01 · FY2007 · CA · contact PI
Tumor drug delivery systems based on polymalic acid$282,225
R01 · FY2006 · CA · contact PI